← Eichor · All briefs

NCT05297045 — Type 2 Diabetes Mellitus trial site landscape

Public-registry site landscape for NCT05297045, a Type 2 Diabetes Mellitus study sponsored by Regor Pharmaceuticals Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT05297045 (registry record)
SponsorRegor Pharmaceuticals Inc.
Condition(s)Type 2 Diabetes Mellitus
PhasePHASE2
Listed sites1
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05297045 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.